Market Intelligence chevron_right Service & Software chevron_right Biologics Regulatory Affairs Outsourcing
Global Report 2025

Global Biologics Regulatory Affairs Outsourcing Market Growth (Status and Outlook) 2025-2031

calendar_todayPublished: Mar 2025 descriptionPages: 132 categoryCategory: Service & Software
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

The global Biologics Regulatory Affairs Outsourcing market size is predicted to grow from US$ 2269 million in 2025 to US$ 3889 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031.

Biologics regulatory affairs outsourcing is a commercial service in which biologics companies entrust regulatory affairs-related work to external professional organizations. Biologics include complex pharmaceutical products such as vaccines, blood products, recombinant proteins, monoclonal antibodies, etc., and the research and development, production, sales and use of these products are subject to strict regulatory supervision.

Regulatory affairs outsourcing involves ensuring that these biologics comply with relevant domestic and international regulatory requirements at all stages, including but not limited to clinical trial applications, drug registrations, license applications, quality standard formulation and maintenance, regulatory compliance supervision, etc.

Key Features

  • Market size growth predictions
  • Global regulatory compliance needs
  • Market segmentation by type and application
  • Geographic breakdown
  • Key players in the market

Segmentation by Type

  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing & Publishing
  • Product Registration
  • Regulatory Submissions
  • Regulatory Operations
  • Others

Segmentation by Application

  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Cell & Gene Therapies
  • Biosimilars
  • Others

Market by Region

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company Coverage

  • Lonza AG
  • Wuxi AppTec Inc.
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific SE
  • Freyr solutions
  • Catalent Inc.
  • Piramal Group
  • AGC Biologics
  • ICON Plc.
  • Charles River Laboratories International, Inc.
  • Labcorp
  • Parexel International
  • Medpace Holdings, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA (SGS)

Key Questions Addressed in this Report

  • What are the growth opportunities in the market?
  • Which factors are driving the market?
  • How are the companies positioning themselves?
  • What are the emerging trends?
  • How will the regulatory landscape affect the market?

Frequently Asked Questions

What is the USP of the report? expand_more
Biologics Regulatory Affairs Outsourcing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Biologics Regulatory Affairs Outsourcing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Biologics Regulatory Affairs Outsourcing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.